305 related articles for article (PubMed ID: 25281955)
21. Comparison of Voxel-Wise and Histogram Analyses of Glioma ADC Maps for Prediction of Early Therapeutic Change.
Chenevert TL; Malyarenko DI; Galbán CJ; Gomez-Hassan DM; Sundgren PC; Tsien CI; Ross BD
Tomography; 2019 Mar; 5(1):7-14. PubMed ID: 30854437
[TBL] [Abstract][Full Text] [Related]
22. Treating anaplastic oligodendrogliomas and WHO grade 2 gliomas: PCV or temozolomide? The case for PCV.
Levin VA
Oncology (Williston Park); 2015 Apr; 29(4):264, 266-8. PubMed ID: 25952490
[No Abstract] [Full Text] [Related]
23. Grading Gliomas Capability: Comparison between Visual Assessment and Apparent Diffusion Coefficient (ADC) Value Measurement on Diffusion-Weighted Imaging (DWI).
Phuttharak W; Thammaroj J; Wara-Asawapati S; Panpeng K
Asian Pac J Cancer Prev; 2020 Feb; 21(2):385-390. PubMed ID: 32102515
[TBL] [Abstract][Full Text] [Related]
24. [Evaluation of ADC mapping as an early predictor for tumor response to chemotherapy in recurrent glioma treated with bevacizumab/irinotecan: proof of principle].
Ringelstein A; Turowski B; Gizewski ER; Schroeteler J; Rapp M; Saleh A; Lanzman RS; Mathys C; Sabel M; Mödder U
Rofo; 2010 Oct; 182(10):868-72. PubMed ID: 20740393
[TBL] [Abstract][Full Text] [Related]
25. Increased diffusion in the normal appearing white matter of brain tumor patients: is this just tumor infiltration?
Horváth A; Perlaki G; Tóth A; Orsi G; Nagy S; Dóczi T; Horváth Z; Bogner P
J Neurooncol; 2016 Mar; 127(1):83-90. PubMed ID: 26614516
[TBL] [Abstract][Full Text] [Related]
26. Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging.
Zeng QS; Li CF; Liu H; Zhen JH; Feng DC
Int J Radiat Oncol Biol Phys; 2007 May; 68(1):151-8. PubMed ID: 17289287
[TBL] [Abstract][Full Text] [Related]
27. Apparent diffusion coefficient maps obtained from high b value diffusion-weighted imaging in the preoperative evaluation of gliomas at 3T: comparison with standard b value diffusion-weighted imaging.
Zeng Q; Dong F; Shi F; Ling C; Jiang B; Zhang J
Eur Radiol; 2017 Dec; 27(12):5309-5315. PubMed ID: 28639047
[TBL] [Abstract][Full Text] [Related]
28. Use of magnetic resonance imaging to assess blood-brain/blood-glioma barrier opening during conformal radiotherapy.
Cao Y; Tsien CI; Shen Z; Tatro DS; Ten Haken R; Kessler ML; Chenevert TL; Lawrence TS
J Clin Oncol; 2005 Jun; 23(18):4127-36. PubMed ID: 15961760
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer.
Roethke MC; Kuder TA; Kuru TH; Fenchel M; Hadaschik BA; Laun FB; Schlemmer HP; Stieltjes B
Invest Radiol; 2015 Aug; 50(8):483-9. PubMed ID: 25867657
[TBL] [Abstract][Full Text] [Related]
30. Correlation of apparent diffusion coefficient with Ki-67 in the diagnosis of gliomas.
Yin Y; Tong D; Liu XY; Yuan TT; Yan YZ; Ma Y; Zhao R
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Oct; 34(5):503-8. PubMed ID: 23134828
[TBL] [Abstract][Full Text] [Related]
31. Differentiation between low-grade and high-grade glioma using combined diffusion tensor imaging metrics.
Ma L; Song ZJ
Clin Neurol Neurosurg; 2013 Dec; 115(12):2489-95. PubMed ID: 24183513
[TBL] [Abstract][Full Text] [Related]
32. Effectiveness of temozolomide treatment used at the same time with radiotherapy and adjuvant temozolomide; concomitant therapy of glioblastoma multiforme: multivariate analysis and other prognostic factors.
Birol Sarica F; Tufan K; Cekinmez M; Sen O; Cem Onal H; Mertsoylu H; Topkan E; Pehlivan B; Erdogan B; Nur Altinors M
J Neurosurg Sci; 2010 Mar; 54(1):7-19. PubMed ID: 20436394
[TBL] [Abstract][Full Text] [Related]
33. Perfusion and diffusion MRI of glioblastoma progression in a four-year prospective temozolomide clinical trial.
Leimgruber A; Ostermann S; Yeon EJ; Buff E; Maeder PP; Stupp R; Meuli RA
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):869-75. PubMed ID: 16226399
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic performance of texture analysis on MRI in grading cerebral gliomas.
Skogen K; Schulz A; Dormagen JB; Ganeshan B; Helseth E; Server A
Eur J Radiol; 2016 Apr; 85(4):824-9. PubMed ID: 26971430
[TBL] [Abstract][Full Text] [Related]
35. Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas.
Brandsma D; Stalpers L; Taal W; Sminia P; van den Bent MJ
Lancet Oncol; 2008 May; 9(5):453-61. PubMed ID: 18452856
[TBL] [Abstract][Full Text] [Related]
36. [Pattern of care of high-grade gliomas].
Laigle-Donadey F; Sanson M
Rev Prat; 2006 Oct; 56(16):1779-86. PubMed ID: 17315503
[TBL] [Abstract][Full Text] [Related]
37. [Pseudonormalization of diffusion weighted images: magnetic resonance imaging in an animal model (C6-glioma)].
Hartmann M; Junkers R; Herold-Mende C; Ahmadi R; Heiland S
Rofo; 2005 Jan; 177(1):114-8. PubMed ID: 15657829
[TBL] [Abstract][Full Text] [Related]
38. Comparison of carbon ion radiotherapy to photon radiation alone or in combination with temozolomide in patients with high-grade gliomas: explorative hypothesis-generating retrospective analysis.
Combs SE; Bruckner T; Mizoe JE; Kamada T; Tsujii H; Kieser M; Debus J
Radiother Oncol; 2013 Jul; 108(1):132-5. PubMed ID: 23932193
[TBL] [Abstract][Full Text] [Related]
39. Prognostic factors and survival in a prospective cohort of patients with high-grade glioma treated with carmustine wafers or temozolomide on an intention-to-treat basis.
Catalán-Uribarrena G; Bilbao-Barandica G; Pomposo-Gaztelu I; Undabeitia-Huertas J; Ruiz de Gopegui-Ruiz E; Galbarriatu-Gutiérrez L; Canales-Llantada M; Aurrecoechea-Obieta J; Igartua-Azkune A; Carbayo-Lozano G
Acta Neurochir (Wien); 2012 Feb; 154(2):211-22; discussion 222. PubMed ID: 22002506
[TBL] [Abstract][Full Text] [Related]
40. Comparison of ADC metrics and their association with outcome for patients with newly diagnosed glioblastoma being treated with radiation therapy, temozolomide, erlotinib and bevacizumab.
Wen Q; Jalilian L; Lupo JM; Molinaro AM; Chang SM; Clarke J; Prados M; Nelson SJ
J Neurooncol; 2015 Jan; 121(2):331-9. PubMed ID: 25351579
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
